Survival and Risk of Leukemic transformation in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study on 1,104 Patients
Tiziano Barbui(University of Bergamo), Ayalew Tefferi(Mayo Clinic), Francesco Passamonti(University of Milan), Irene Bertozzi(University of Padua), Alessandra Carobbio(Ospedale Papa Giovanni XXIII), Valentina Carrai(University of Bergamo), Filippo Marino(Università Cattolica del Sacro Cuore), Emanuela Boveri(Policlinico San Matteo Fondazione), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Maria Luigia Randi(University of Padua), Heinz Gisslinger(Medical University of Vienna), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Andrea Gianatti(University of Bergamo), Elisa Rumi(University of Pavia), Elisabetta Antonioli(Azienda Ospedaliero-Universitaria Careggi), Marco Ruggeri(Ospedale San Bortolo), Curtis A. Hanson(Toyota Motor Corporation (Switzerland)), Jüergen Thiele(University of Cologne), Emanuele S.G. dʼAmore(Ospedale San Bortolo), Leonhard Müllauer(Hochschule Campus Wien), Francesco Rodeghiero(Ospedale San Bortolo), Naseema Gangat(Mayo Clinic in Arizona)
Cited by 15
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2019|735